DOMINO. E F Optmd-halh. lnogen mtera~ ttons PHARMACOL BIOCHEM BEHAV 24(2) [401][402][403][404][405] 1986 --Before the advent of neurolepncs, oplo,ds such as morphine were used occasionally m the treatment of sch~zophrema and other mental dasorders Recent interest m the possible therapeunc role of endogenous op~oad peptldes m various mental states has prompted a new look at the opaoads The present paper summarizes the research to date m the author's laboratory on opaoad-hallucmogen anteractaons A model behaworal state was reduced in rats wath N,N-&methyltryptamme (DMT) or lyserglc acad dlethylamlde-25 (LSD) Several mu opaoad agomsts, antagomsts, and synthenc enkephahn analogs interacted wath DMT and LSD Adult male Holtzman rats trained on a posahve reinforcement fixed ratio four (FR4) behavaoral schedule 0 e , a reward of 0 01 ml sugar-sweetened mdk was earned on every fourth bar press) were used m these studies DMT (3 2 and 10 0 mg/kg) gaven with a 0 9% NaCI pretreatment IP, disrupted estabhshed food rewarded FR4 bar pressing behavior m a dose related fashion Pre-determmed behavaorally meffecuve doses ofmu opaoad agomsts showed selectave blphasac effects a~zamst DMT and LSD Low doses anta~omzed the effects of both hallucinogens, whereas larger doses enhanced their effects in contrast to the antagomsUc effects of low doses ofmu opaoad agomsts, the mu-kappa opaoad antagorest (-)-naloxone enhanced the effects of DMT and LS (-)-Naloxone enhanced the effects of DMT and LSD Potentiation of DMT-mduced behavaoral d~sruptaon was attnbuted to a stereospecffic opaoad antagomst effect of (-)-naloxone in that the (+)-naloxone enanuomer failed to potentmte the effects of DMT Further studies are indicated to determine hallucmogenoplold anteracnons m various species, including man The present findings reinforce a possable antagomst role of opload substances m mental processes revolving hallucananons DMT LSD Oplold-halluclnogen interactions 1N recent years, the role of endogenous oplolds in human psychoses has been extensively studied At best, one can conclude that thew interaction is complex and far from clear For the past 10 years my colleagues and I have used ammal models of psychotic states reduced by DMT, LSD and other hallucinogens Our working hypothesis is that drugs which enhance or reduce the effects of DMT, LSD or PCP may shed hght on the acnons of these hallucinogens and possibly have relevance to human psychoses, or at least to human hallucinogen abuse Antagomsts of various hallucinogens should have therapeutic utdity m the management of "bad trips " The present paper summarizes our own stu&es on DMT and LSD-oplold interactions which have been pubhshed in detad previously [1, 5, 6, 7] 
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METHOD

Subje~ t.s
Male Holtzman rats at least 90 days old were maintained at approximately 70% of the//" expected free feeding weight and housed individually m a rodent facility where constant temperature and humidity were maintained
Pt o~ edure
Rats were tramed to press a bar for one hour dally using 0 O1 ml of sugar sweetened, water diluted evaporated mdk as a positive reinforcement The milk was prepared by combining 400 ml of evaporated milk with 400 ml of tap water and 60 g of granulated sugar Daily experiments were conducted in a darkened, isolated room using Lehigh Valley Electronics rodent operant test cages model 143-21 The dally bar-pressing schedule was fixed ratio four (FR4), i e , every fourth bar press earned a milk reward Cumulative recorders automatically recorded bar presses, reinforcements, and any disruption of normal bar pressing Upon stabilization of the FR4 behavior, each rat was subjected to a dally schedule of one hour of bar pressing for a mmlmum of 5 days prior to any mject~ons The training and testing procedures were s~mllar to those previously described by Kovaclc and Domino [2] Animals used in this study were usually drug free for a minimum of 7 days prior to the experiment and had no past history of being given long-acting compounds Rats served as thew own controls to compare the effect of a hallucinogen with and w~thout naloxone pretreatment All rats were scheduled In randomly assigned groups Drug-free intervals of 1 week were observed for all pretreatment groups Because of the short duration of action of DMT, less than a full week was accepted as a drug-free interval for the DMT control groups Doses of DMT (1 0, 3 2, and 10 0 mg/kg) or LSD (0 1 mg/kg) were admlmstered IP to disrupt food-rewarded fixed rano bar pressmg m a dose related fashion Log doses of naloxone (1 0, 2 4, 3 2, and 5 6 mg/kg), which had no effect on normal bar pressing behavior for periods up to 60 ~Supported m part by the Psychopharmacology Research Fund (Domino) 
Chemu al Method~
Unfasted male Holtzman rats, weighing approximately 500 g were used for the chemical analysis Pretreated rats were injected with naloxone 3 2 mg/kg (IP) 5 minutes prior to ~4C-DMT 10 rag/3 /xC~/kg, IP Control rats recewed only ]~C-DMT 10 mg/3 /xCl/kg (IP) The rats were sacrificed by gmllotlne 30 and 90 minutes after I~C-DMT injection The enure brain and approximately 2 g of hver from each rat were ~mmedlately removed and homogenized in ice cold 1 N HCI The homogenates were assayed for total radioactivity, total acidic metabohtes, and DMT [4] N,N-Dlmethyltryptamme side chain-l-~4C-hydrogen oxalate was purchased from New England Nuclear. Boston, MA The ~4C-DMT 10 rag/3 p.Ci/ml solution was prepared by m~xmg nonradioactive DMT with radioactive DMT The duraUon of the drug effect was measured by the horlzontal line generated by the cumulative recorder during the cessauon of normal bar pressing Since both onset and recovery of DMT and LSD effects are sudden and complete, the duration of the drug effect could easily be calculated from the length of the horizontal segment To stausUcally analyze these data, two-taded Student t-tests were calculated using the value of p<0 05 as slgmficant
RESULTS
A( ute DMT EjJe~ ts
Increasing doses of DMT given IP caused progressively longer disruption of bar pressing (Fig I) The mean_+S E suppression of bar pressing for groups of 6--8 rats was determined for each dose As can be seen. a dose of I mg/kg of DMT caused httle or no disruption of bar pressing A dose of 3 2 mg/kg of DMT caused the rats to stop bar pressing for about 25 minutes, whde 10 mg/kg abohshed bar pressing for about 50 minutes A very large dose of 32 mg/kg of DMT disrupted bar pressing for about 150 minutes However, the rats had marked motor symptoms including convulsions A dose of 0 1 mg/kg of LSD IP suppressed bar pressing for 30-50 minutes in control groups of rats (Fig 3) This dose caused comparable suppression of FR4 behavior to about 10 mg/kg of DMT Naloxone pretreatment (1 0 to 5 6 mg/kg) caused a similar potentiation of LSD disruptive effects
Fadure oJ Naloxone Pretreatment to Alter I4C-DMT Bram and Ltve: Levels
Rat brain and liver levels of I4C-DMT were assayed to determine whether naloxone pretreatment was interfering with DMT bIotransformatlon In this experiment, a dose of 10 mg/kg, IP of non-radioactive DMT caused about 60 minutes of suppression of bar pressing which was prolonged 3 fold to about 180 minutes (p<0 001) by 3 2 mg/kg of naloxone, as shown in the left hand portion of Fig 4 Control untrained groups of rats were given 10 mg/kg of DMT contaming 3 p.Cl of ~4C-DMT and their brains and hvers removed 30 and 90 minutes later The mean levels of radioactivity of these groups were compared to rats receiving 3 2 mg/kg of naloxone pretreatment plus the same of non-radloacUve and ~4C-DMT When analyzed by group comparison Student t-tests, no significant differences were found in brain or liver I4C-DMT, total radioactivity, or ~4C-acldlc metabohtes
Stereospe~ tfic EfJec ts of Naloxone Enantu~mers
The differential effects of (+) and (-)-naloxone pretreatment on DMT-induced disruption of FR4 bar pressing behavlor are shown in Fig 5 Only the ( ) enantlomer was effective (/9<0 01) in enhancing the effects of DMT m the doses used
EJJe~ ts of Mu Opu)td AA, omst~
Morphine and methadone in doses of 0 32, 1 0, and 3 2 mg/kg IP prior to DMT (32 and 10 mg/kg) or LSD (0 1 mg/kg) showed blphaslc dose dependent effects (Fig 6) Slgmficant antagonism of DMT-and LSD-mduced behavioral suppression occurred with the smaller doses of morphine and methadone Some differences were observed between the two opiolds, as shown m Fig 6 The two synthetic oplold met-enkephahn m pepude analogs, FK 33-824 and LY 127623, were also effective m antagonizing the behavioral disruptive effects of DMT and LSD, as illustrated in Figs 7 and 8 
DISCUSSION
The evidence that the opiate antagonist (-)-naloxone enhances the behavioral effects of DMT and LSD ~s impressive This effect is not due to increased brain or liver levels of DMT Furthermore, small doses of mtt oplmd agomsts antagonize DMT and LSD behaworal effects Thus, the data obtained substantiate ~mportant interactions of the Indole hallucinogens with oplmds in the rat and strengthen the ewdence for involvement of endogenous oplmds m the pathogenesis of chemically induced psychoses The dramaUc hallucinogen antagonistic effects of LY 127623 and FK33-824 are especially interesting and parallel the findings of morphine and methadone with DMT and LSD These results suggest that DMT and LSD effects are modulated by a specific and selective oplold agonist action It would be of interest to extend these findings using Lappa oplold agonlsts as well To date, all of our studies revolve the use of oplold agomsts as pretreatments Oplold agomsts also should be given after DMT or LSD to determine ff op~old posttreatment will reduce the duration of hallucinogen acUon If effective under these latter condmons, human trials mvolvmg hallucinogen induced "bad trips" treated with small doses of oplolds would be logical to conduct
